Undecimal Bio
Undecimal Bio develops delivery molecules that help RNA medicines reach specific tissues, with initial research programmes in kidney and vascular disease.
$18MSeed
ParticipantEC
Entrée Capital
entreecap.com ↗Activity from announced rounds
Activity in this selectionOct 17, 2026 · Sep 18, 2026
Venture investing across software, fintech, deep tech, AI and blockchain, with recorded financing activity from seed through later stages.
A founder-led investment firm
Entrée Capital is an investment firm led by former serial founders, with offices in Tel Aviv, London and New York. Its stated areas include software, fintech, deep tech, AI and blockchain. The firm manages multiple funds and publishes a portfolio spanning early and growth-stage businesses.
Activity recorded in RoundOS
Recorded events include Chamelio’s Series A, Catch’s seed financing, Alta’s Series A and Archy’s later-stage financing. The list also includes events involving Guidde, Lasso Security and Zocks. These are financing events covered by RoundOS; Entrée’s own directory provides its broader portfolio.
Sources
- Rounds participated in
- 2
- Confirmed lead rounds
- 1 All roles disclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $44M 2 disclosed · full round size, not this investor’s share